These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32353382)

  • 21. Association of Low Vitamin D Levels With Noninfectious Anterior Uveitis.
    Grotting LA; Davoudi S; Palenzuela D; Papaliodis GN; Sobrin L
    JAMA Ophthalmol; 2017 Feb; 135(2):150-153. PubMed ID: 28006052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes and Complications Associated with Noninfectious Uveitis in Patients Presenting with Rhegmatogenous Retinal Detachment.
    Slingsby TJ; Pecen PE; Palestine AG
    Ophthalmol Retina; 2020 Aug; 4(8):823-828. PubMed ID: 32307330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema.
    Levin MH; Pistilli M; Daniel E; Gangaputra SS; Nussenblatt RB; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Jabs DA; Levy-Clarke GA; Kempen JH;
    Ophthalmology; 2014 Feb; 121(2):588-95.e1. PubMed ID: 24332536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of non-infectious uveitis or myasthenia gravis in patients on checkpoint inhibitors in a large healthcare claims database.
    Xia T; Brucker AJ; McGeehan B; VanderBeek BL
    Br J Ophthalmol; 2022 Jan; 106(1):87-90. PubMed ID: 33087313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-eclampsia/Eclampsia as a Risk Factor of Noninfectious Uveitis Among Postdelivery Women.
    Chen WD; Yang YH; Lee CY; Lai CH; Liu CY; Lai LJ
    Am J Ophthalmol; 2019 Feb; 198():166-173. PubMed ID: 30316670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials.
    Sheppard J; Joshi A; Betts KA; Hudgens S; Tari S; Chen N; Skup M; Dick AD
    JAMA Ophthalmol; 2017 Jun; 135(6):511-518. PubMed ID: 28426849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time Trade-off Utility Values in Noninfectious Uveitis.
    Niemeyer KM; Gonzales JA; Doan T; Browne EN; Rao MM; Acharya NR
    Am J Ophthalmol; 2019 Dec; 208():47-55. PubMed ID: 31201795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy.
    Letko E; Yeh S; Foster CS; Pleyer U; Brigell M; Grosskreutz CL;
    Ophthalmology; 2015 May; 122(5):939-48. PubMed ID: 25638011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of choroidal neovascularization among the uveitides.
    Baxter SL; Pistilli M; Pujari SS; Liesegang TL; Suhler EB; Thorne JE; Foster CS; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Kempen JH
    Am J Ophthalmol; 2013 Sep; 156(3):468-477.e2. PubMed ID: 23795984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis: Post Hoc Analyses from the VISUAL-1 and VISUAL-2 Trials.
    Suhler EB; Thorne JE; Mittal M; Betts KA; Tari S; Camez A; Bao Y; Joshi A
    Ophthalmology; 2017 Dec; 124(12):1799-1807. PubMed ID: 28689898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between Smoking and Uveitis: Results from the Pacific Ocular Inflammation Study.
    Yuen BG; Tham VM; Browne EN; Weinrib R; Borkar DS; Parker JV; Uchida A; Vinoya AC; Acharya NR
    Ophthalmology; 2015 Jun; 122(6):1257-61. PubMed ID: 25835263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypopyon in patients with uveitis.
    Zaidi AA; Ying GS; Daniel E; Gangaputra S; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Kempen JH;
    Ophthalmology; 2010 Feb; 117(2):366-72. PubMed ID: 20006905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing Uveitis Risk following Pediatric Down Syndrome Diagnosis: A TriNetX Database Study.
    Hsu AY; Wang YH; Lin CJ; Li YL; Hsia NY; Lai CT; Kuo HT; Chen HS; Tsai YY; Wei JC
    Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792893
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk of Retinal Neovascularization in Cases of Uveitis.
    Patel AK; Newcomb CW; Liesegang TL; Pujari SS; Suhler EB; Thorne JE; Foster CS; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Sen HN; Artornsombudh P; Kothari S; Kempen JH;
    Ophthalmology; 2016 Mar; 123(3):646-54. PubMed ID: 26686964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence, prevalence, and risk factors of infectious uveitis and scleritis in the United States: A claims-based analysis.
    Zhang Y; Amin S; Lung KI; Seabury S; Rao N; Toy BC
    PLoS One; 2020; 15(8):e0237995. PubMed ID: 32841267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis.
    Loh AR; Acharya NR
    Am J Ophthalmol; 2010 Oct; 150(4):534-542.e2. PubMed ID: 20643395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Outcomes of Treatment with Biological Agents in Eyes with Refractory, Active, Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.
    Al-Janabi A; El Nokrashy A; Sharief L; Nagendran V; Lightman S; Tomkins-Netzer O
    Ophthalmology; 2020 Mar; 127(3):410-416. PubMed ID: 31607412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral corticosteroid exposure and increased risk of related complications in patients with noninfectious intermediate, posterior, or panuveitis: Real-world data analysis.
    Chirikov VV; Shah R; Kwon Y; Patel D
    Ophthalmic Epidemiol; 2019 Feb; 26(1):27-46. PubMed ID: 30199301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Novel Oral Antithrombotics With the Risk of Intraocular Bleeding.
    Uyhazi KE; Miano T; Pan W; VanderBeek BL
    JAMA Ophthalmol; 2018 Feb; 136(2):122-130. PubMed ID: 29242919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Challenge of Pediatric Uveitis: Tertiary Referral Center Experience in the United States.
    Ferrara M; Eggenschwiler L; Stephenson A; Montieth A; Nakhoul N; Araùjo-Miranda R; Foster CS
    Ocul Immunol Inflamm; 2019; 27(3):410-417. PubMed ID: 29333911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.